Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Chemfab Alkalis Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue ₹75.61 Cr (-1.24% YoY, +3.35% QoQ); operational EBITDA ₹7.04 Cr at 9.31% margin; PBT loss ₹2.95 Cr. Chemicals recovery offset by OPVC collapse.

Highlights
Revenue growthConsolidated -1.24% YoY, +3.35% QoQ
MarginsEBITDA margin 9.31%, down 454 bps QoQ
Demand visibilityOPVC enquiries rising; large-diameter tenders
Management confidenceCautiously optimistic; expects H2 improvement

Growth

Chemicals revenue ₹69.22 Cr (+38.94% YoY); OPVC revenue ₹6.39 Cr (-76.10% YoY). Chemicals EBITDA swung to ₹7.30 Cr from loss.

Outlook

Management expects stronger consolidated H2 FY27 and visible OPVC revenue pickup from Q3 FY27. Caustic prices bottomed Oct 2026. No numeric guidance.

Risks

ECU realisation fell to ₹38,000/MT from ₹39,600 QoQ; OPVC EBITDA negative at -₹0.26 Cr; government fund-release timing risk.

Source

Investor Presentation filed with BSE, NSE: CHEMFAB. Summary written with AI assistance from the document.

Read the document ↗

Chemfab Alkalis Ltd: key numbers

Share price
₹309.35
Market cap
₹444.6 Cr
Revenue (annual)
₹311.0 Cr
Net profit (annual)
₹-3.43 Cr
P/E (TTM)
-1304.0×Sector 34.1×
Promoter holding
72.13%+0.00% QoQ
FII holding
0.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Chemfab Alkalis Ltd

All →